LT2987793T - Heterociklinis acto rūgšties amido junginys - Google Patents

Heterociklinis acto rūgšties amido junginys

Info

Publication number
LT2987793T
LT2987793T LTEP14786115.7T LT14786115T LT2987793T LT 2987793 T LT2987793 T LT 2987793T LT 14786115 T LT14786115 T LT 14786115T LT 2987793 T LT2987793 T LT 2987793T
Authority
LT
Lithuania
Prior art keywords
acetic acid
acid amide
amide compound
heterocyclic acetic
heterocyclic
Prior art date
Application number
LTEP14786115.7T
Other languages
English (en)
Inventor
Ryota Shiraki
Takahiko Tobe
Shimpei Kawakami
Hiroyuki Moritomo
Makoto OHMIYA
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of LT2987793T publication Critical patent/LT2987793T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LTEP14786115.7T 2013-04-18 2014-04-18 Heterociklinis acto rūgšties amido junginys LT2987793T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013087151 2013-04-18
PCT/JP2014/061007 WO2014171528A1 (ja) 2013-04-18 2014-04-18 ヘテロ環酢酸アミド化合物

Publications (1)

Publication Number Publication Date
LT2987793T true LT2987793T (lt) 2018-01-10

Family

ID=51729480

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14786115.7T LT2987793T (lt) 2013-04-18 2014-04-18 Heterociklinis acto rūgšties amido junginys

Country Status (33)

Country Link
US (2) US8937087B2 (lt)
EP (1) EP2987793B1 (lt)
JP (1) JP6252582B2 (lt)
KR (1) KR102193247B1 (lt)
CN (1) CN105121435B (lt)
AR (1) AR095883A1 (lt)
AU (1) AU2014254768B2 (lt)
BR (1) BR112015026512B1 (lt)
CA (1) CA2909783C (lt)
CY (1) CY1119754T1 (lt)
DK (1) DK2987793T3 (lt)
EA (1) EA028968B1 (lt)
ES (1) ES2651866T3 (lt)
HK (1) HK1214248A1 (lt)
HR (1) HRP20171786T1 (lt)
HU (1) HUE036054T2 (lt)
IL (1) IL241962B (lt)
LT (1) LT2987793T (lt)
ME (1) ME02891B (lt)
MX (1) MX2015014646A (lt)
MY (1) MY175971A (lt)
NO (1) NO2987793T3 (lt)
NZ (1) NZ713118A (lt)
PH (1) PH12015502341A1 (lt)
PL (1) PL2987793T3 (lt)
PT (1) PT2987793T (lt)
RS (1) RS56865B1 (lt)
SA (1) SA515370015B1 (lt)
SG (1) SG11201508448RA (lt)
SI (1) SI2987793T1 (lt)
TW (1) TWI625329B (lt)
UA (1) UA116243C2 (lt)
WO (1) WO2014171528A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR105025A1 (es) 2015-06-19 2017-08-30 Astellas Pharma Inc Compuesto de imidazodiazepina
TWI725408B (zh) 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
CN112912377A (zh) 2018-09-13 2021-06-04 拜耳公司 作为害虫防治剂的杂环衍生物
CN110590576A (zh) * 2019-08-15 2019-12-20 安徽金禾实业股份有限公司 一种4-多氟代甲氧基邻苯二胺的制备方法
CN114380709B (zh) * 2021-12-31 2023-07-21 西北农林科技大学 4-氯-2-酰氨基酚的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6627624B1 (en) 1999-04-02 2003-09-30 Neurogen Corporation Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
EP1165557B1 (en) 1999-04-02 2004-09-29 Neurogen Corporation ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
AUPQ309399A0 (en) 1999-09-28 1999-10-21 Fujisawa Pharmaceutical Co., Ltd. Benzothiazoline derivatives
ES2349118T3 (es) 2001-09-14 2010-12-28 High Point Pharmaceuticals, Llc Nuevos derivados de aminoazetidina, pirrolidina y piperidina.
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
CA2478183C (en) 2002-03-12 2010-02-16 Merck & Co. Inc. Substituted amides
AU2004222383B2 (en) 2003-03-14 2009-10-01 Merck Sharp & Dohme Corp. Bicyclic anilide spirohydantoin CGRP receptor antagonists
EP1719761A4 (en) * 2004-02-23 2007-10-10 Dainippon Sumitomo Pharma Co NEW HETEROCYCLIC CONNECTION
JP4914346B2 (ja) 2004-05-27 2012-04-11 ユセベ ファルマ ソシエテ アノニム ベンズオキサゾロン誘導体、その調製方法及びその使用
US7790726B2 (en) 2005-08-16 2010-09-07 Chemocentryx, Inc. Monocyclic and bicyclic compounds and methods of use
WO2007044804A2 (en) 2005-10-11 2007-04-19 Chemocentryx, Inc. Piperidine derivatives and methods of use
CL2007002097A1 (es) 2006-07-20 2008-01-18 Smithkline Beecham Corp Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
US7786157B2 (en) 2007-03-16 2010-08-31 Chemocentryx, Inc. OXO-imidazolidines as modulators of chemokine receptors
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
GB0713686D0 (en) * 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2

Also Published As

Publication number Publication date
NO2987793T3 (lt) 2018-03-24
HK1214248A1 (zh) 2016-07-22
TWI625329B (zh) 2018-06-01
AU2014254768A1 (en) 2015-11-05
ME02891B (me) 2018-04-20
CN105121435A (zh) 2015-12-02
US20150045402A1 (en) 2015-02-12
CN105121435B (zh) 2017-09-29
ES2651866T3 (es) 2018-01-30
CA2909783C (en) 2021-02-02
EP2987793A4 (en) 2016-09-07
MX2015014646A (es) 2016-03-01
EA201591988A1 (ru) 2016-02-29
EP2987793B1 (en) 2017-10-25
UA116243C2 (uk) 2018-02-26
BR112015026512B1 (pt) 2023-03-14
PL2987793T3 (pl) 2018-05-30
BR112015026512A2 (pt) 2017-07-25
EP2987793A1 (en) 2016-02-24
JPWO2014171528A1 (ja) 2017-02-23
PH12015502341B1 (en) 2016-02-22
AU2014254768B2 (en) 2017-10-05
SA515370015B1 (ar) 2017-11-27
US8937087B2 (en) 2015-01-20
IL241962B (en) 2019-03-31
SI2987793T1 (en) 2018-02-28
US20140315963A1 (en) 2014-10-23
CY1119754T1 (el) 2018-06-27
US9708307B2 (en) 2017-07-18
DK2987793T3 (en) 2017-12-18
WO2014171528A1 (ja) 2014-10-23
HRP20171786T1 (hr) 2018-02-23
CA2909783A1 (en) 2014-10-23
RS56865B1 (sr) 2018-04-30
NZ713118A (en) 2019-03-29
KR20150143468A (ko) 2015-12-23
HUE036054T2 (hu) 2018-06-28
PT2987793T (pt) 2017-12-19
EA028968B1 (ru) 2018-01-31
MY175971A (en) 2020-07-19
AR095883A1 (es) 2015-11-18
JP6252582B2 (ja) 2017-12-27
PH12015502341A1 (en) 2016-02-22
KR102193247B1 (ko) 2020-12-22
TW201518298A (zh) 2015-05-16
SG11201508448RA (en) 2015-11-27

Similar Documents

Publication Publication Date Title
EP3026051A4 (en) Heterocyclic compound
HK1210769A1 (en) Heterocyclic compound
EP3029031A4 (en) Heterocyclic compound
EP2889291A4 (en) HETEROCYCLIC CONNECTION
EP2982666A4 (en) HETEROCYCLIC COMPOUND
EP2832734A4 (en) HETEROCYCLIC CONNECTION
EP2881386A4 (en) amide
EP2873669A4 (en) HETEROCYCLIC COMPOUND
EP3018123A4 (en) Amide compound
EP2818473A4 (en) HETEROCYCLIC COMPOUND
HK1221465A1 (zh) 新型雜環化合物
HK1225372A1 (zh) 氨基酸衍生物
RU2016118399A3 (en) 4-aminomethylbenzoic acid derivative
EP3018126A4 (en) HETEROCYCLIC COMPOUND
EP3006444A4 (en) HETEROCYCLIC AMIDE COMPOUND
EP2857400A4 (en) HETEROCYCLIC COMPOUND
EP2955179A4 (en) CONDENSED HETEROCYCLIC COMPOUND
EP2927229A4 (en) HETEROCYCLIC COMPOUND
EP2975031A4 (en) Heterocyclic compound
EP2980089A4 (en) HETEROCYCLIC CONNECTION
EP3061754A4 (en) Heterocyclic compound
HRP20190133T1 (hr) Heterociklički spoj
EP2955178A4 (en) CONDENSED HETEROCYCLIC COMPOUND
EP2982670A4 (en) HETEROCYCLIC COMPOUND
HK1214248A1 (zh) 雜環乙酰胺化合物